Hospital-acquired infections may be lower in closed ICUs

May 22, 2019

ATS 2019, Dallas, TX -- Three hospital-acquired infections rates appear to be lower in patients admitted to a "closed" intensive care unit, meaning that the ICU team has primary responsibility for the patient, rather than a primary care physician, according to research presented at ATS 2019. Central line-associated blood stream infections (CLABSI), catheter-associated urinary tract infections (CAUTI) and ventilator-acquired pneumonia (VAP) were lower after a medical center transitioned from an open to a closed ICU, while methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. Diff) rates remained the same.
-end-
VIEW ABSTRACT

CONTACT FOR MEDIA

Ahmad Sharayah, MD
drsharayah@gmail.com

Session: D44 Critical Care: An Encounter - How We Manage Critical Care In and Out of the ICU
Abstract Presentation Time: Wednesday, May 22, 11:15 a.m. CT
Location: Area E (Hall F, Level 2), Kay Bailey Hutchison Convention Center Dallas

American Thoracic Society

Related MRSA Articles from Brightsurf:

Widely available antibiotics could be used in the treatment of 'superbug' MRSA
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research from an international collaboration led by scientists at the University of Cambridge and the Wellcome Sanger Institute.

Computer model shows how to better control MRSA outbreaks
A research team led by scientists at the Columbia University Mailman School of Public Health report on a new method to help health officials control outbreaks of methicillin-resistant Staphylococcus aureus, or MRSA, a life-threatening antibiotic-resistant infection often seen in hospitals.

Using MRSA's strength against it
MRSA evolved to become a deadly killer because it's wily and resilient.

Livestock-associated MRSAfound among MRSA from humans
The survey results show more frequent detections and geographical dispersion of LA-MRSA in humans in the EU/EEA since 2007, and highlight the public health and veterinary importance of LA-MRSA as a 'One Health' issue.

Fighting MRSA with new membrane-busting compounds
Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA).

Know thy enemy: Kill MRSA with tailored chemistry
UConn medicinal chemists have developed experimental antibiotics that kill MRSA, a common and often deadly bacteria that causes skin, lung, and heart infections.

MRSA uses decoys to evade a last-resort antibiotic
The superbug MRSA uses decoys to evade a last-resort antibiotic, reveals new research.

Scientists find a salty way to kill MRSA
Scientists have discovered a new way to attack Staphylococcus aureus bacteria.

Experimental antibiotic treats deadly MRSA infection
A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA.

OU team develops new antibiotic to fight MRSA
A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant infectious bacteria.

Read More: MRSA News and MRSA Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.